Male birth control pill: A New Reality

-From lab to life: A non-hormonal male birth control pill was proven to be safe in its first human trial.

---

Headaches, nausea, bloating, vomiting, migraines, weight gain, and acne. These are just a few of the side effects of oral contraceptives taken by millions of women daily. The only available contraceptive methods for men as of now are condoms and vasectomies, but what if there were a way to prevent conception and not deal with the abundance of side effects caused by commonly used female contraceptive devices? Well, the wait is now over. The first-ever hormone-free male birth control pill was shown to be safe in a human trial!

This pill, known as YCT-529, works by actively targeting a vitamin A metabolite (retinoic acid) receptor. It inhibits retinoic acid from binding to its receptor in the testes, hence preventing the sperm-making process (spermatogenesis). This oral drug caused infertility in mice after 4 weeks of taking the drug and in non-human primates after 2 weeks of taking it, without any adverse side effects. The animals regained fertility after the treatment was stopped. These results laid the groundwork for evaluating YCT-529 in human clinical trials.

About the human clinical trial:

The first phase of the clinical trial was completed successfully in 2024. The trial included 16 healthy men aged 32 to 59. These men were infertile and had undergone previous vasectomies, as the purpose of the trial was not to determine the drug's efficacy but its tolerability and bioavailability, i.e., the proportion of a drug present in the blood available for active use. The participants were split into two groups and given varying dosages of the drug. The trial’s results substantiated the drug's good bioavailability, which means that it does not break down rapidly in the body; hence, it doesn't have to be administered more than once a day. The research team did not note any adverse side effects related to the drug either. The drug is currently undergoing safety and efficacy testing in a second clinical trial. 

With unintentional pregnancy rates at nearly 50% globally, more contraceptive options, especially for men, are the need of the hour. Several other reversible male birth control methods are now in clinical trials as well. NES/T, a gel-based contraceptive, is the furthest along in clinical trials. The future of male contraceptive methods looks bright, with so much research underway, as well as the interest of the general public, who knows what’s to come?